But threats to the industry loom as brands take work in-house.
You've seen what the biggies can do. What about the smaller end of the spectrum? MM&M's second buyer's guide to pharma, healthcare, and life sciences consulting services focuses on the dos and don'ts of hiring boutique firms.
Talukdar will lead the firm's advisory practice, VantageRx.
Do the healthcare and pharma arms of Accenture, Deloitte, PwC, and other consultancies pose an existential threat to traditional healthcare agencies?
The consultancy includes Double Helix, which was acquired by McCann in 2012.